Sponsor pipeline

Donald Arnold clinical trial pipeline

Get alerts when Donald Arnold's trials change

1 active trials 0 recruiting 3 disease areas 3 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Not applicable
NCT06947044 Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding Acute Leukemia Active, Not Recruiting 2026-10-09

Disease areas by active trials

Acute Lymphoblastic Leukemia (ALL) (1) · Acute Myeloid Leukemia (AML) (1) · Leukemia (1)

Get alerts when Donald Arnold's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free